SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-212735
Filing Date
2019-08-05
Accepted
2019-08-05 12:01:32
Documents
4
Period of Report
2019-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d97507d8k.htm 8-K 17885
2 EX-99.1 d97507dex991.htm EX-99.1 27318
3 GRAPHIC g97507g0805184826300.jpg GRAPHIC 2355
4 GRAPHIC g97507g0805184826488.jpg GRAPHIC 4350
  Complete submission text file 0001193125-19-212735.txt   55914
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 19998003
SIC: 2836 Biological Products, (No Diagnostic Substances)